251 BALLARDVALE ST, WILMINGTON, MA
Shareholders Approve 2026 Long-Term Incentive Plan at Annual Meeting
Announces First-Quarter 2026 Results
Annual Report to Security Holders
Charles River Laboratories Announces Planned Divestiture of CDMO and Cell Sol...
Announces Fourth-Quarter and Full-Year 2025 Results and Provides 2026 Guidance
CFO Appointment - Glenn Coleman Named Chief Financial Officer
Earnings Release
CEO Transition - James C. Foster Steps Down; Birgit Girshick Appointed
Q1
FY 2024
Q3
Q2
FY 2023
Registration Statement for Securities to be Offered to Employees
S-3ASR
Definitive Proxy Statement
Additional Proxy Materials
Statement of Changes in Beneficial Ownership
Specialized Disclosure Report
Submission Upload
Correspondence